PCM Trials, an independent mobile research nurse visit provider for decentralized clinical trials, completed the acquisition of EmVenio Research, a provider of community-based clinical trial sites served with mobile research units. Financial terms were not disclosed. "The acquisition of EmVenio is an important part of our company's overall strategy to further remove barriers for patients of all backgrounds and ethnicities to participate in clinical research, creating the most patient-centric clinical trial model. Our pioneering approach to using Certified Mobile Research Nurses who visit patients in their homes has already been shown to improve both patient retention and diversity in clinical trials and drive faster study completion. Now, with the addition of EmVenio's mobile research site network, we have the unmatched ability to provide additional convenience for prospective participants, empowering community-based clinical trial access," Greg Austin, PCM Trials President.